Turn complex healthcare data into clear, context-rich insights that drive faster, smarter decisions.

Direct patient engagement by life sciences manufacturers is at an all-time high. I am not just referring to direct-to-consumer advertising. Manufacturers are increasingly engaging patients through ...

Small businesses are struggling with rising costs and tariffs, but many are still looking to maintain or increase health coverage, according to a recent report from Chase.

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

A new Trilliant Health report reveals vast price variation for identical healthcare services, even for procedures delivered at the exact same facility. Allison Oakes, Trilliant’s chief research ...

Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and ...

Hospital margins improved in June as revenue gains outpaced patient volume — but Kaufman Hall’s latest data shows that financial gaps between high- and low-performing organizations persist, with ...

Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved.

Even with venture capital fundraising slowing down, Hatteras Venture Partners was able to close two new funds for investments in seed- and early-stage companies. We also have a recap of recent ...

Health plan sponsors have more flexibility and opportunities than before to improve healthcare access and steer their workforce toward high-quality, high-value care.